US 10184124
RNA interference in ocular indications
granted A61KA61K31/713A61K45/06
Quick answer
US patent 10184124 (RNA interference in ocular indications) held by Phio Pharmaceuticals Corp. expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Phio Pharmaceuticals Corp.
- Grant date
- Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/713, A61K45/06, A61K47/554, A61K9/0048